MD vs FMS vs CON Stock Comparison

Pediatrix Medical, Fresenius Medical Care AG and Concentra Group Holdings Parent Prices as of Oct 26, 2026 Peers: Industry group
FMS Fresenius Medical Care AG
$22.76 +0.4% 1M -16.4% 1Y
Market cap
$13.10B
P/E
12.0x
Revenue (TTM)
$11.07B
Div. yield
–
Healthcare Services Healthcare
4 wins

Head to Head

11 decided of 12

Fresenius Medical Care AG leads on 4 of the 12 questions below (Fresenius Medical Care AG 4, Concentra Group Holdings Parent 4, Pediatrix Medical 3). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionMDFMSCONLeader
Larger companyMarket capitalisation $2.30B $13.10B $5.00B FMS
Cheaper on earningsLower P/E, profitable companies only 13.1x 12.0x 25.2x FMS
Cheaper on forward earningsLower price / next fiscal year consensus EPS 12.1x 9.6x 23.4x FMS
Faster revenue growthRevenue growth, trailing twelve months +0.5% -47.8% +14.0% CON
More profitableNet margin, trailing twelve months 9.0% 9.9% 8.7% FMS
Better return on capitalReturn on invested capital 11.3% 0.2% 14.2% CON
Less leveragedLower net debt / EBITDA 0.8x 200.7x 3.1x MD
Higher dividend yieldTrailing dividend yield 0.00% 0.00% 0.01% –
Better 1-year returnPrice return, last 12 months +64.9% -16.4% +92.3% CON
Better 5-year returnAnnualised price return, 5 years +1.0%/yr -8.0%/yr — MD
Less volatileAnnualised volatility, 1 year 41.3% 31.1% 27.9% CON
Higher overall scoreMean of the five percentile scores vs peers 70/100 50/100 57/100 MD

Percentile Scorecard

MDFMSCON

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisMDFMSCON
Valuation 91 #9 of 93 72 #27 of 93 59 #39 of 93
Growth 38 #55 of 88 12 #78 of 88 64 #32 of 88
Profitability 81 #17 of 87 62 #34 of 87 86 #13 of 87
Financial Health 59 #42 of 100 13 #87 of 100 27 #73 of 100
Shareholder Returns 82 #11 of 56 91 #6 of 56 51 #28 of 56
Overall 70 50 57
  • MD ranked among 103 companies in Healthcare Providers
  • FMS ranked among 103 companies in Healthcare Providers
  • CON ranked among 103 companies in Healthcare Providers

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodMDFMSCONSPY
1 month +10.4%+0.4%+14.9% -0.8%
3 months +11.1%-8.5%+26.0% +3.5%
6 months +24.1%+0.6%+77.4% +7.0%
Year to date +35.7%-4.5%+104.4% +12.2%
1 year +64.9%-16.4%+92.3% +13.0%
3 years +156.4%+38.8%— +86.3%
3 years, per year +36.9%+11.6%— +23.1%
5 years +5.3%-33.9%— +68.6%
5 years, per year +1.0%-8.0%— +11.0%
10 years -55.4%-43.7%— +258.0%
10 years, per year -7.7%-5.6%— +13.6%

Risk

MeasureMDFMSCONSPY
Volatility, 1Y 41.3%31.1%27.9% 12.7%
Downside volatility, 1Y 39.0%37.0%23.2% 12.7%
Beta vs S&P 500, 1Y 0.340.200.42 1.00
Return / volatility, 1Y 1.57-0.533.31 1.02
Max drawdown, 5Y -76.4%-63.9%-23.5% -25.4%
From 52-week high -1.8%-16.3%0.0% -1.8%
52-week high $29.54$27.20$40.22 $779.14
52-week low $16.97$20.19$18.71 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleMDFMSCON
P/E now vs peer median 13.2xmedian 25.1x 12.1xmedian 25.1x 25.3xmedian 25.1x
P/S now vs peer median 1.2xmedian 1.6x 1.1xmedian 1.6x 2.2xmedian 1.6x
EV/EBITDA now vs peer median 10.6xmedian 14.5x 205.4xmedian 14.5x 14.3xmedian 14.5x
P/FCF now vs peer median 10.3xmedian 22.4x 6.1xmedian 22.4x 19.2xmedian 22.4x
P/B now vs peer median 2.7xmedian 3.1x 0.8xmedian 3.1x 10.6xmedian 3.1x
PEG now vs peer median 0.66median 0.66 0.58median 0.66 —median 0.66

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsMDFMSCON
Revenue $1.95B $11.07B $2.29B
Gross profit – -$5.62B $670.56M
Operating income $215.42M $879.32M $374.81M
Net income $174.81M $1.38B $203.80M
Free cash flow $229.94M $2.08B $267.42M
R&D – $180.01M –
EPS (diluted) $2.15 $1.79 $1.56
Cash & equivalents $288.88M $1.21B $158.04M
Total debt $584.24M $572.99B $1.57B
Shares (diluted) 81.41M 612.52M 127.79M
Enterprise value $600.61M $5.05B $4.65B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricMDFMSCON
P/E 13.2x 12.1x 25.3x
P/FCF 10.3x 6.1x 19.2x
P/Operating cash flow 9.5x 3.9x 15.3x
P/S 1.2x 1.1x 2.2x
P/B 2.7x 0.8x 10.6x
P/Tangible book 2.7x 0.9x 20.3x
EV/EBITDA 10.6x 205.4x 14.3x
EV/EBIT 11.8x 628.4x 17.5x
EV/Revenue 1.3x 49.9x 2.9x
EV/FCF 11.0x 265.7x 24.5x
EV/Operating cash flow 10.2x 167.5x 19.5x
PEG (3Y EPS CAGR) 0.66 0.58 –

Growth

14 metrics
MetricMDFMSCON
Revenue growth (1Y) 0.5% -47.8% 14.0%
Revenue CAGR (3Y) -0.8% -18.6% –
Gross profit growth (1Y) – -207.2% 18.9%
Gross profit CAGR (3Y) – -45.2% –
Operating income growth (1Y) 30.5% -45.5% 18.9%
Operating income CAGR (3Y) 10.0% -16.4% –
Net income growth (1Y) 59.0% 49.8% 32.6%
Net income CAGR (3Y) 19.3% 18.2% –
EPS growth (1Y) 67.1% 52.0% 33.5%
EPS CAGR (3Y) 19.9% 20.9% –
Operating cash flow growth (1Y) -3.6% 9.3% 29.2%
Operating cash flow CAGR (3Y) 10.2% 9.3% –
Free cash flow growth (1Y) -4.2% -7.7% 43.1%
Free cash flow CAGR (3Y) 14.2% 4.8% –

Profitability

14 metrics
MetricMDFMSCON
Gross margin – -50.7% 29.3%
EBITDA margin 12.3% 24.3% 20.0%
Operating margin 11.0% 7.9% 16.4%
Pretax margin 11.6% 15.8% 11.7%
Net margin 9.0% 9.9% 8.7%
FCF margin 11.8% 18.8% 11.7%
Operating cash flow margin 12.7% 29.8% 14.7%
Return on equity 19.9% 2.7% 44.8%
Return on assets 8.3% 1.2% 7.0%
Return on invested capital 11.3% 0.2% 14.2%
Return on capital employed 13.5% 3.2% 14.5%
Asset turnover 0.9x 0.3x 0.8x
Cash conversion (OCF / net income) 1.4x 2.4x 1.6x
Stock comp / revenue 1.0% – 0.6%

Financial Health

11 metrics
MetricMDFMSCON
Debt / assets 27.4% 1,515% 52.3%
Debt / equity 0.7x 35.0x 3.2x
Net debt / EBITDA 0.8x 200.7x 3.1x
Debt / FCF 2.5x 260.4x 5.9x
Liabilities / assets 58.6% 56.8% 83.9%
Equity / assets 41.4% 43.2% 16.1%
Interest coverage 6.3x 2.0x –
Current ratio 1.3x 1.1x 1.4x
Quick ratio 1.3x 0.2x 1.2x
Cash ratio 0.8x 0.2x 0.4x
Altman Z-score 2.46 1.33 2.56

Shareholder Returns

7 metrics
MetricMDFMSCON
Dividend yield – 3.8% 0.6%
Net buyback yield 6.2% 8.5% 0.5%
Shareholder yield 6.2% 12.3% 1.1%
Payout ratio (earnings) – – 15.7%
Payout ratio (FCF) – – 12.0%
Dividend growth (1Y) – – 33.4%
Dividend CAGR (3Y) – – –

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusMDFMSCON
Forward P/E 12.1xFY2026 9.6xFY2026 23.4xFY2026
EPS, next fiscal year $2.40FY2026 $2.37FY2026 $1.72FY2026
EPS growth, next FY +17.6%FY2026 -6.0%FY2026 +25.5%FY2026
EPS growth, the year after -0.4% +7.6% +10.5%
Revenue, next fiscal year $1.86BFY2026 $21.50BFY2026 $2.30BFY2026
Revenue growth, next FY -2.5%FY2026 -7.0%FY2026 +6.3%FY2026
Revenue growth, the year after +3.8% -0.3% +3.1%
MD estimates →FMS estimates →CON estimates →

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersMDFMSCON
Held by institutions 100.0% 7.3% 87.3%
Institutions holding 301 235 291
Change in shares held, QoQ +1.1% -2.9% +4.0%
Institutions buying 153 151 166
Institutions selling 101 41 81
Buyers to sellers 1.51 3.68 2.05
MD holders →FMS holders →CON holders →

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

MDFMSCON
MD 1.00 0.21 0.23
FMS 0.21 1.00 0.27
CON 0.23 0.27 1.00

Add a Peer

Largest companies in the same industry
MD · Healthcare Services
+DVADavita +RDNTRadNet +LFSTLifeStance Health +SGRYSurgery Partners +PRVAPrivia Health +PGNYProgyny +USPHU S Physical Therapy +STLNStarling Oncology
Plot all 36 Healthcare Services stocks →

Related Comparisons

MD vs DVADavita MD vs RDNTRadNet MD vs LFSTLifeStance Health MD vs SGRYSurgery Partners

Frequently Asked Questions

Which is bigger, MD, FMS and CON?

Fresenius Medical Care AG (FMS) is the largest by market capitalisation: Pediatrix Medical (MD) $2.30B, Fresenius Medical Care AG (FMS) $13.10B, Concentra Group Holdings Parent (CON) $5.00B.

Which stock is cheaper, MD, FMS and CON?

Fresenius Medical Care AG (FMS) trades on the lowest price-to-earnings ratio (Pediatrix Medical (MD) 13.1x, Fresenius Medical Care AG (FMS) 12.0x, Concentra Group Holdings Parent (CON) 25.2x). On next year's consensus earnings, Fresenius Medical Care AG (FMS) is cheapest (Pediatrix Medical (MD) 12.1x, Fresenius Medical Care AG (FMS) 9.6x, Concentra Group Holdings Parent (CON) 23.4x). A lower multiple can reflect slower expected growth, so read it next to the growth figures.

Which company is growing faster?

Concentra Group Holdings Parent (CON) grew revenue fastest over the trailing twelve months: Pediatrix Medical (MD) +0.5%, Fresenius Medical Care AG (FMS) -47.8%, Concentra Group Holdings Parent (CON) +14.0%.

Which company is more profitable?

Fresenius Medical Care AG (FMS) has the highest net margin (Pediatrix Medical (MD) 9.0%, Fresenius Medical Care AG (FMS) 9.9%, Concentra Group Holdings Parent (CON) 8.7%). On return on invested capital, Concentra Group Holdings Parent (CON) leads (Pediatrix Medical (MD) 11.3%, Fresenius Medical Care AG (FMS) 0.2%, Concentra Group Holdings Parent (CON) 14.2%).

Which stock has performed better?

Over the past year Concentra Group Holdings Parent (CON) returned the most: Pediatrix Medical (MD) +64.9%, Fresenius Medical Care AG (FMS) -16.4%, Concentra Group Holdings Parent (CON) +92.3%. Over five years, Pediatrix Medical (MD) compounded fastest (Pediatrix Medical (MD) +1.0%/yr, Fresenius Medical Care AG (FMS) -8.0%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Only one of these companies pays a dividend: Pediatrix Medical (MD) 0.00%, Fresenius Medical Care AG (FMS) 0.00%, Concentra Group Holdings Parent (CON) 0.01%. Pediatrix Medical (MD) and Fresenius Medical Care AG (FMS) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Concentra Group Holdings Parent (CON) has been the steadiest (Pediatrix Medical (MD) 41.3%, Fresenius Medical Care AG (FMS) 31.1%, Concentra Group Holdings Parent (CON) 27.9%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, MD, FMS and CON?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Fresenius Medical Care AG (FMS) leads on 4. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.